Role of target geometry in phagocytosis
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Phagocytosis is a principal component of the body’s innate immunity in which macrophages internalize targets in an actin-dependent manner. Targets vary widely in shape and size and include particles such as pathogens and senescent cells. Despite considerable progress in understanding this complicated process, the role of target geometry in phagocytosis has remained elusive. Previous studies on phagocytosis have been performed using spherical targets, thereby overlooking the role of particle shape. Using polystyrene particles of various sizes and shapes, we studied phagocytosis by alveolar macrophages. We report a surprising finding that particle shape, not size, plays a dominant role in phagocytosis. All shapes were capable of initiating phagocytosis in at least one orientation. However, the local particle shape, measured by tangent angles, at the point of initial contact dictates whether macrophages initiate phagocytosis or simply spread on particles. The local shape determines the complexity of the actin structure that must be created to initiate phagocytosis and allow the membrane to move over the particle. Failure to create the required actin structure results in simple spreading and not internalization. Particle size primarily impacts the completion of phagocytosis in cases where particle volume exceeds the cell volume.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
Foged, C., Brodin, B., Frokjaer, S., & Sundblad, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.035 · Cited by 871
Phagocytosis and the actin cytoskeleton
May, R. C., & Machesky, L. M. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.6.1061 · Cited by 715
Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage
Tabata, Y., & Ikada, Y. (1988) · Biomaterials · doi:10.1016/0142-9612(88)90033-6 · Cited by 538
Cellular Control of Actin Nucleation
Welch, M. D., & Mullins, R. D. (2002) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.18.040202.112133 · Cited by 517
Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target
Beningo, K. A., & Wang, Y.-L. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.4.849 · Cited by 389
Preparation of monodisperse ellipsoidal polystyrene particles
Ho, C. C., Keller, A., Odell, J. A., & Ottewill, R. H. (1993) · Colloid & Polymer Science · doi:10.1007/bf00657391 · Cited by 386
The macrophage capacity for phagocytosis
Cannon, G. J., & Swanson, J. A. (1992) · Journal of Cell Science · doi:10.1242/jcs.101.4.907 · Cited by 289
Palecanda, A., Paulauskis, J., Al-Mutairi, E., Imrich, A., Qin, G., Suzuki, H., Kodama, T., Tryggvason, K., Koziel, H., & Kobzik, L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1497 · Cited by 244
Actin dynamics during phagocytosis
Castellano, F., Chavrier, P., & Caron, E. (2001) · Seminars in Immunology · doi:10.1006/smim.2001.0331 · Cited by 181
Cited by
Items 101–189 of 189
Endocytosis of Gene Delivery Vectors: From Clathrin-dependent to Lipid Raft-mediated Endocytosis
El-Sayed, A., & Harashima, H. (2013) · Molecular Therapy · doi:10.1038/mt.2013.54 · Cited by 345
Toxicity of Nanomaterials: Exposure, Pathways, Assessment, and Recent Advances
Ganguly, P., Breen, A., & Pillai, S. C. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00068 · Cited by 341
Health Concerns of Various Nanoparticles: A Review of Their in Vitro and in Vivo Toxicity
Ajdary, M., Moosavi, M. A., Rahmati, M., Falahati, M., Mahboubi, M., Mandegary, A., Jangjoo, S., Mohammadinejad, R., & Varma, R. S. (2018) · Nanomaterials · doi:10.3390/nano8090634 · Cited by 340
Layer‐By‐Layer‐Assembled Capsules and Films for Therapeutic Delivery
Becker, A. L., Johnston, A. P. R., & Caruso, F. (2010) · Small · doi:10.1002/smll.201000379 · Cited by 336
Breaking Down the Barriers to Precision Cancer Nanomedicine
von Roemeling, C., Jiang, W., Chan, C. K., Weissman, I. L., & Kim, B. Y. S. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.07.006 · Cited by 330
Towards clinically translatable in vivo nanodiagnostics
Park, S.-M., Aalipour, A., Vermesh, O., Yu, J. H., & Gambhir, S. S. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.14 · Cited by 327
Modulation of Immune Responses by Particle Size and Shape
Baranov, M. V., Kumar, M., Sacanna, S., Thutupalli, S., & van den Bogaart, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.607945 · Cited by 324
Macrophages Recognize Size and Shape of Their Targets
Doshi, N., & Mitragotri, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010051 · Cited by 321
Self-citationIn vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery
Jain, A. K., & Thareja, S. (2019) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2018.1561457 · Cited by 319
Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy
Zhai, Y., Su, J., Ran, W., Zhang, P., Yin, Q., Zhang, Z., Yu, H., & Li, Y. (2017) · Theranostics · doi:10.7150/thno.20118 · Cited by 312
Margination of micro- and nano-particles in blood flow and its effect on drug delivery
Müller, K., Fedosov, D. A., & Gompper, G. (2014) · Scientific Reports · doi:10.1038/srep04871 · Cited by 312
Erythrocyte‐Inspired Delivery Systems
Hu, C. J., Fang, R. H., & Zhang, L. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200138 · Cited by 308
The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions?
Rivolta, I., Panariti, & Miserocchi (2012) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s25515 · Cited by 308
Shape and size-dependent immune response to antigen-carrying nanoparticles
Kumar, S., Anselmo, A. C., Banerjee, A., Zakrewsky, M., & Mitragotri, S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.069 · Cited by 307
Self-citationChallenges in design and characterization of ligand-targeted drug delivery systems
Muro, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.052 · Cited by 307
Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers
Caldorera-Moore, M., Guimard, N., Shi, L., & Roy, K. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903579971 · Cited by 304
Doshi, N., Prabhakarpandian, B., Rea-Ramsey, A., Pant, K., Sundaram, S., & Mitragotri, S. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.007 · Cited by 301
Self-citationHunter, Z., McCarthy, D. P., Yap, W. T., Harp, C. T., Getts, D. R., Shea, L. D., & Miller, S. D. (2014) · ACS Nano · doi:10.1021/nn405033r · Cited by 301
The Shape of Things to Come: Importance of Design in Nanotechnology for Drug Delivery
Liu, Y., Tan, J., Thomas, A., Ou-Yang, D., & Muzykantov, V. R. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.156 · Cited by 299
PRINT: A Novel Platform Toward Shape and Size Specific Nanoparticle Theranostics
Perry, J. L., Herlihy, K. P., Napier, M. E., & DeSimone, J. M. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000315 · Cited by 290
Christian, D. A., Cai, S., Garbuzenko, O. B., Harada, T., Zajac, A. L., Minko, T., & Discher, D. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900022m · Cited by 289
Auría-Soro, C., Nesma, T., Juanes-Velasco, P., Landeira-Viñuela, A., Fidalgo-Gomez, H., Acebes-Fernandez, V., Gongora, R., Almendral Parra, M. J., Manzano-Roman, R., & Fuentes, M. (2019) · Nanomaterials · doi:10.3390/nano9101365 · Cited by 289
Sustained-release from nanocarriers: a review
Natarajan, J. V., Nugraha, C., Ng, X. W., & Venkatraman, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.029 · Cited by 285
Inorganic nanoparticles in clinical trials and translations
Huang, H., Feng, W., Chen, Y., & Shi, J. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100972 · Cited by 283
Broad‐Spectrum Antibacterial Activity of Carbon Nanotubes to Human Gut Bacteria
Chen, H., Wang, B., Gao, D., Guan, M., Zheng, L., Ouyang, H., Chai, Z., Zhao, Y., & Feng, W. (2013) · Small · doi:10.1002/smll.201202792 · Cited by 283
Design considerations for nanotherapeutics in oncology
Stylianopoulos, T., & Jain, R. K. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.07.015 · Cited by 280
The cytoskeleton in phagocytosis and macropinocytosis
Mylvaganam, S., Freeman, S. A., & Grinstein, S. (2021) · Current Biology · doi:10.1016/j.cub.2021.01.036 · Cited by 263
The Receptor-Mediated Endocytosis of Nonspherical Particles
Decuzzi, P., & Ferrari, M. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.120238 · Cited by 278
Controlling the morphology of electrospray-generated PLGA microparticles for drug delivery
Almería, B., Deng, W., Fahmy, T. M., & Gomez, A. (2010) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2009.10.002 · Cited by 277
Nano–bio effects: interaction of nanomaterials with cells
Cheng, L.-C., Jiang, X., Wang, J., Chen, C., & Liu, R.-S. (2013) · Nanoscale · doi:10.1039/c3nr34276j · Cited by 276
Nanoparticle elasticity regulates phagocytosis and cancer cell uptake
Hui, Y., Yi, X., Wibowo, D., Yang, G., Middelberg, A. P. J., Gao, H., & Zhao, C.-X. (2020) · Science Advances · doi:10.1126/sciadv.aaz4316 · Cited by 276
Polymer particles that switch shape in response to a stimulus
Yoo, J.-W., & Mitragotri, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000346107 · Cited by 275
Self-citationPolymeric Materials for Gene Delivery and DNA Vaccination
Nguyen, D. N., Green, J. J., Chan, J. M., Langer, R., & Anderson, D. G. (2009) · Advanced Materials · doi:10.1002/adma.200801478 · Cited by 273
Yoo, J.-W., Doshi, N., & Mitragotri, S. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.004 · Cited by 272
Self-citationSelf-folding devices and materials for biomedical applications
Randall, C. L., Gultepe, E., & Gracias, D. H. (2012) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.06.013 · Cited by 269
Enhancing cell therapies from the outside in: Cell surface engineering using synthetic nanomaterials
Stephan, M. T., & Irvine, D. J. (2011) · Nano Today · doi:10.1016/j.nantod.2011.04.001 · Cited by 266
Li, L., Liu, T., Fu, C., Tan, L., Meng, X., & Liu, H. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.07.004 · Cited by 262
Exocytosis of nanoparticles from cells: Role in cellular retention and toxicity
Sakhtianchi, R., Minchin, R. F., Lee, K.-B., Alkilany, A. M., Serpooshan, V., & Mahmoudi, M. (2013) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2013.10.013 · Cited by 262
Challenges in design of translational nanocarriers
Sun, Q., Radosz, M., & Shen, Y. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.042 · Cited by 261
Metallodrugs in cancer nanomedicine
Peña, Q., Wang, A., Zaremba, O., Shi, Y., Scheeren, H. W., Metselaar, J. M., Kiessling, F., Pallares, R. M., Wuttke, S., & Lammers, T. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00468a · Cited by 259
Attarilar, S., Yang, J., Ebrahimi, M., Wang, Q., Liu, J., Tang, Y., & Yang, J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00822 · Cited by 257
Frontiers in the treatment of glioblastoma: Past, present and emerging
Janjua, T. I., Rewatkar, P., Ahmed-Cox, A., Saeed, I., Mansfeld, F. M., Kulshreshtha, R., Kumeria, T., Ziegler, D. S., Kavallaris, M., Mazzieri, R., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.012 · Cited by 257
Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows
Lee, S.-Y., Ferrari, M., & Decuzzi, P. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/49/495101 · Cited by 257
Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery
Vaughan, H. J., Green, J. J., & Tzeng, S. Y. (2020) · Advanced Materials · doi:10.1002/adma.201901081 · Cited by 255
Exosomes are endogenous nanoparticles that can deliver biological information between cells
Sun, D., Zhuang, X., Zhang, S., Deng, Z.-B., Grizzle, W., Miller, D., & Zhang, H.-G. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.002 · Cited by 250
“This phenomenon is greatly influenced by actin mechanics at the points of particle contact with a macrophage [86].”
BackgroundBenne, N., van Duijn, J., Kuiper, J., Jiskoot, W., & Slütter, B. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.033 · Cited by 248
Liposome-like nanostructures for drug delivery
Gao, W., Hu, C.-M. J., Fang, R. H., & Zhang, L. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb21238f · Cited by 244
Jain, N., Moeller, J., & Vogel, V. (2019) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-062117-121224 · Cited by 237
Rougerie, P., Miskolci, V., & Cox, D. (2013) · Immunological Reviews · doi:10.1111/imr.12118 · Cited by 237
“Also, it has recently been demonstrated that the IgG coating is not sufficient, as certain shapes are not suitable for engulfment (29).”
BackgroundDi, J., Gao, X., Du, Y., Zhang, H., Gao, J., & Zheng, A. (2021) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2020.07.005 · Cited by 229
Inam, M., Cambridge, G., Pitto-Barry, A., Laker, Z. P. L., Wilson, N. R., Mathers, R. T., Dove, A. P., & O'Reilly, R. K. (2017) · Chemical Science · doi:10.1039/c7sc00641a · Cited by 219
Responsive layer-by-layer materials for drug delivery
Wohl, B. M., & Engbersen, J. F. J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.035 · Cited by 215
Current research trends of nanomedicines
Liu, Q., Zou, J., Chen, Z., He, W., & Wu, W. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.05.018 · Cited by 213
“Smaller particles favor protein attachment due to a higher surface area-to-volume ratio 195,196 .”
BackgroundCan Controversial Nanotechnology Promise Drug Delivery?
Devadasu, V. R., Bhardwaj, V., & Kumar, M. N. V. R. (2013) · Chemical Reviews · doi:10.1021/cr300047q · Cited by 210
Wibroe, P. P., Anselmo, A. C., Nilsson, P. H., Sarode, A., Gupta, V., Urbanics, R., Szebeni, J., Hunter, A. C., Mitragotri, S., Mollnes, T. E., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.47 · Cited by 205
Self-citationEffects of Microparticle Size and Fc Density on Macrophage Phagocytosis
Pacheco, P., White, D., & Sulchek, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060989 · Cited by 205
“Numerous studies on phagocytosis have shown that particle size greatly affects the average number of microparticles internalized by the macrophage [17,18,25], but these did not address the impact of Fc density on internalization.”
BackgroundDesign Strategies and Applications of Circulating Cell-Mediated Drug Delivery Systems
Su, Y., Xie, Z., Kim, G. B., Dong, C., & Yang, J. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/ab500179h · Cited by 179
Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery
Zhou, Z., Ma, X., Jin, E., Tang, J., Sui, M., Shen, Y., Van Kirk, E. A., Murdoch, W. J., & Radosz, M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.012 · Cited by 178
The Impact of Aspect Ratio on the Biodistribution and Tumor Homing of Rigid Soft‐Matter Nanorods
Shukla, S., Eber, F. J., Nagarajan, A. S., DiFranco, N. A., Schmidt, N., Wen, A. M., Eiben, S., Twyman, R. M., Wege, C., & Steinmetz, N. F. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201400641 · Cited by 177
Drug Delivery with polymeric nanocarriers-cellular uptake mechanisms
Nelemans, L. C., & Gurevich, L. (2020) · Materials · doi:10.3390/ma13020366 · Cited by 173
Protein-based nanoparticles in cancer vaccine development
Neek, M., Kim, T. I., & Wang, S.-W. (2019) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2018.09.004 · Cited by 172
Review of Aquatic Toxicity of Pharmaceuticals and Personal Care Products to Algae
Xin, X., Huang, G., & Zhang, B. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124619 · Cited by 170
Agarwal, R., Jurney, P., Raythatha, M., Singh, V., Sreenivasan, S. V., Shi, L., & Roy, K. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500441 · Cited by 169
Leveraging Physiology for Precision Drug Delivery
Sun, W., Hu, Q., Ji, W., Wright, G., & Gu, Z. (2017) · Physiological Reviews · doi:10.1152/physrev.00015.2016 · Cited by 169
Gao, H., & He, Q. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.877442 · Cited by 164
“To quantitatively elucidate the role of geometry in internalization, W is defined as the angle of the membrane normalized to the point of initial contact [35].”
BackgroundVillanueva-Flores, F., Castro-Lugo, A., Ramírez, O. T., & Palomares, L. A. (2020) · Nanotechnology · doi:10.1088/1361-6528/ab5bc8 · Cited by 164
“Local particle shape, measured by tangent angles, at the point of initial contact dictates whether macrophages initiate phagocytosis or simply spread on particles (Champion and Mitragotri 2006).”
BackgroundLoverde, S. M., Klein, M. L., & Discher, D. E. (2012) · Advanced Materials · doi:10.1002/adma.201103192 · Cited by 162
Nanocrystals: a perspective on translational research and clinical studies
Jarvis, M., Krishnan, V., & Mitragotri, S. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10122 · Cited by 162
“the pathways of NPs differing in shape, size, and aspect ratio in mouse peritoneal macrophages.(58) Large particles (>100 nm) are usually inter-”
BackgroundSelf-citationTumor Microenvironment Targeted Nanotherapy
Fernandes, C., Suares, D., & Yergeri, M. C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01230 · Cited by 161
Liu, J., Zhang, R., & Xu, Z. P. (2019) · Small · doi:10.1002/smll.201900262 · Cited by 161
Lewis, L. E., Bain, J. M., Lowes, C., Gillespie, C., Rudkin, F. M., Gow, N. A. R., & Erwig, L.-P. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002578 · Cited by 150
“This in turn may reflect differences in the wall chemistry of the hyphal tip compared to the mother cell, or be due to the efficiency of the assembly of proteins of the phagocytic cup for objects of different sizes and shapes [45].”
BackgroundFusion, fission, and secretion during phagocytosis
Huynh, K. K., Kay, J. G., Stow, J. L., & Grinstein, S. (2007) · Physiology · doi:10.1152/physiol.00028.2007 · Cited by 105
“Even the shape of the prey is now thought to influence the machinery that is engaged for engulfment (8).”
BackgroundTa, H. T., Truong, N. P., Whittaker, A. K., Davis, T. P., & Peter, K. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1316262 · Cited by 105
Microglia-targeting nanotherapeutics for neurodegenerative diseases
Zhao, N., Francis, N. L., Calvelli, H. R., & Moghe, P. V. (2020) · APL Bioengineering · doi:10.1063/5.0013178 · Cited by 104
Phagocytic ‘teeth’ and myosin-II ‘jaw’ power target constriction during phagocytosis
Vorselen, D., Barger, S. R., Wang, Y., Cai, W., Theriot, J. A., Gauthier, N. C., & Krendel, M. (2021) · eLife · doi:10.7554/elife.68627 · Cited by 85
Filamentous morphology of bacteria delays the timing of phagosome morphogenesis in macrophages
Prashar, A., Bhatia, S., Gigliozzi, D., Martin, T., Duncan, C., Guyard, C., & Terebiznik, M. R. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201304095 · Cited by 76
“JCB: Article”
Creatine kinase-mediated ATP supply fuels actin-based events in phagocytosis
Kuiper, J. W. P., Pluk, H., Oerlemans, F., van Leeuwen, F. N., de Lange, F., Fransen, J., & Wieringa, B. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060051 · Cited by 75
“avoid that effects of o ther properties of the target, such as rigidity and geometry, would influence the outcom e of our study [36,37], we deliberately chose to change only the type of coat, no t the particle type (i.”
BackgroundPadmore, T., Stark, C., Turkevich, L. A., & Champion, J. A. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.09.031 · Cited by 74
Self-citationDynamics of Macrophage Trogocytosis of Rituximab-Coated B Cells
Pham, T., Mero, P., & Booth, J. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014498 · Cited by 66
“Particle shape is a key parameter constraining the efficiency of phagocytosis [26,27].”
BackgroundQi, Y.-T., Zhang, F.-L., Tian, S.-Y., Wu, H.-Q., Zhao, Y., Zhang, X.-W., Liu, Y.-L., Fu, P., Amatore, C., & Huang, W.-H. (2024) · Nature Nanotechnology · doi:10.1038/s41565-023-01575-0 · Cited by 65
Multiscale Modeling in the Clinic: Drug Design and Development
Clancy, C. E., An, G., Cannon, W. R., Liu, Y., May, E. E., Ortoleva, P., Popel, A. S., Sluka, J. P., Su, J., Vicini, P., et al. (2016) · Annals of Biomedical Engineering · doi:10.1007/s10439-016-1563-0 · Cited by 62
Li, T., Nowell, C. J., Cipolla, D., Rades, T., & Boyd, B. J. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01308 · Cited by 57
Pollastri, S., D’Acapito, F., Trapananti, A., Colantoni, I., Andreozzi, G. B., & Gualtieri, A. F. (2015) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2015.05.010 · Cited by 51
Size-dependent biodistribution and antitumor efficacy of polymer micelle drug delivery systems
Yue, J., Liu, S., Xie, Z., Xing, Y., & Jing, X. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20296h · Cited by 51
Phagocytosis: what’s on the menu?
Lancaster, C. E., Ho, C. Y., Hipolito, V. E. B., Botelho, R. J., & Terebiznik, M. R. (2019) · Biochemistry and Cell Biology · doi:10.1139/bcb-2018-0008 · Cited by 49
Karmali, P. P., Chao, Y., Park, J.-H., Sailor, M. J., Ruoslahti, E., Esener, S. C., & Simberg, D. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200375x · Cited by 36
Rivera, K. O., Cuylear, D. L., Duke, V. R., O’Hara, K. M., Zhong, J. X., Elghazali, N. A., Finbloom, J. A., Kharbikar, B. N., Kryger, A. N., Miclau, T., et al. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1190371 · Cited by 22
Castoldi, A., Empting, M., De Rossi, C., Mayr, K., Dersch, P., Hartmann, R., Müller, R., Gordon, S., & Lehr, C.-M. (2019) · Pharmaceutical Research · doi:10.1007/s11095-018-2521-3 · Cited by 22
Biocompatibility and toxicity challenges of nanomaterials
Yaşayan, G., Alarcin, E., Avci-Adali, M., Ipek, T. C., Nejati, O., Özcan-Bülbül, E., Karslı, S., Bal-Öztürk, A., & Mostafavi, E. (2024) · Functionalized Nanomaterials for Cancer Research · doi:10.1016/b978-0-443-15518-5.00019-7 · Cited by 8
Metadata
- Authors
- Champion, J. A., & Mitragotri, S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2006-03-20
- Volume
- 103
- Issue
- 13
- Pages
- 4930-4934
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2015497529
- Cited by
- 2,074
- References
- 20
- FWCI
- 13.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.